Who Paid My Doc
Rapid Pathogen Screening, Inc.
CA, United States
CMS manufacturer 100000010778
General payments
$0
Research payments
$1,445,336
Ownership & investment interest
$2,398,189
Through program year 2022, Rapid Pathogen Screening, Inc. reported paying $0 in general payments and $1,445,336 in research payments to U.S. physicians, teaching hospitals and other recipients.
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $56,359 | 12 |
| 2021 | Research | $639,722 | 36 |
| 2020 | Research | $639,709 | 49 |
| 2019 | Research | $109,545 | 9 |
Breakdown
Grouped by name only. CMS publishes no corporate ownership, so a shared name does not mean a shared parent.
Records
106 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers of drugs, devices and biologicals, and group purchasing organisations, are required to report the payments and transfers of value they make to physicians and teaching hospitals. This page shows what this company reported.